Triangle Venture Capital Group

Triangle is few European venture capital firms with an exclusive focus on investments in research spin-offs. Since its inception in 1997, Triangle has advised three fund generations (managing over €100 million): FirstGen, which started investing in 1999, Fund IV, with vintage year 2006, and the Open Sky Technologies Fund in collaboration with the European Space Agency (ESA), with vintage year 2010. The three fund generations have invested in 16 start-up companies with Triangle investing as lead investor in all portfolio companies and completing more than 100 transactions, including follow-on funding rounds and exits. Some €150 million has been committed to these companies, with funds from co-investors as well as Triangle-advised funds. They understand, however, that Venture Capital is not for all companies. Their passion for empowering entrepreneurs led them to start a crowdinvesting platform FunderNation which leverages on their VC background and combines it with the wisdom of the online community.

Xin Chen Ph.D

Investment Manager

Doerr, Hans-Henning

CFO and Partner

François Gaillard

Senior Investment Manager, Partner

Bernd Geiger

Managing General Partner

Joerg Kreisel

Venture Partner

Wiebke Langhans

Senoir Investment Manager, Partner

Anthony Park

Venture Partner

Dirk Raab

Partner, CFO

John Rosati

Venture Partner

Vitalijs Stafejevs

Financial Analyst

11 past transactions

Argos Therapeutics

Series E in 2013
Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus. Its products include AGS-0031 for metastatic renal cell carcinoma; AGS-0041 for HIV; CD83 soluble protein for transplant rejection/autoimmune disorders; Anti IFN-alpha monoclonal antibody2 for lupus; and regulatory T cell therapy3 for autoimmune disorders. The company was formerly known as MERIX Bioscience, Inc. Argos Therapeutics was founded in 1997 and is based in Durham, North Carolina.

TakWak

Series A in 2010
TakWak GmbH, a Munich, Germany-based producer of a device that can be compared with digital cameras or mp3 players.

iOpener

Series B in 2008
iOpener provides and facilitates Real-time data into games and virtual worlds. Its patented technology uses satellite navigation technology. iOpener participated in the [European Space Agency Business incubation initiative](http://www.esa.int/SPECIALS/TTP2/SEMNVNRMTWE_0.html).

iOpener

Series A in 2008
iOpener provides and facilitates Real-time data into games and virtual worlds. Its patented technology uses satellite navigation technology. iOpener participated in the [European Space Agency Business incubation initiative](http://www.esa.int/SPECIALS/TTP2/SEMNVNRMTWE_0.html).

iPharro Media

Series A in 2007
iPharro Media is on the forefront of the digital asset management revolution, enabling companies along every step of the media value chain to identify, monetize and even protect video content. iPharro MediaSeeker technology is a superior, scalable content analysis platform that can be readily adapted to virtually any relevant business application iPharro uses state of the art, sophisticated software to analyze and immediately identify video clips by comparing them to a database of known video information. The flagship iPharro MediaSeeker software product allows customers to easily and efficiently monitor multiple broadcast television channels in order to detect desired content using patent pending video fingerprinting technology
Klastech Karpushko Laser Technology engages in the development, manufacture, and sale of diode pumped solid state lasers. Its products are core models of lasers in green and blue spectrum range. Klastech Karpushko Laser Technology’s lasers are used in equipment for semiconductor production and pharmaceutical industries, and in scientific applications. It began operation in 2006, with its headquarters in Dortmund in Germany as a subsidiary of Power Technology as of January 30, 2013.

fg microtec

Venture Round in 2006
fg microtec GmbH provides multimedia applications for 2.5G, 3G, and WLAN mobile phones. Its products include OMA/IMS compliant push-over-cellular clients, IMS and SIP based VoIP solutions, videotelephony, and video sharing over 3G and WLAN networks. The company also provides embedded software solutions, push to talk over cellular solutions, embedded applications, layered architectures, OMA enabler conformance tests, and data streams and protocols. It serves mobile phone manufacturers. The company was founded in 2000 and is based in Munich, Germany with an additional office in Zagreb, Croatia.

fg microtec

Series B in 2005
fg microtec GmbH provides multimedia applications for 2.5G, 3G, and WLAN mobile phones. Its products include OMA/IMS compliant push-over-cellular clients, IMS and SIP based VoIP solutions, videotelephony, and video sharing over 3G and WLAN networks. The company also provides embedded software solutions, push to talk over cellular solutions, embedded applications, layered architectures, OMA enabler conformance tests, and data streams and protocols. It serves mobile phone manufacturers. The company was founded in 2000 and is based in Munich, Germany with an additional office in Zagreb, Croatia.

Attensity

Series B in 2003
Attensity is a provider of corporate insight solutions based on proprietary data contextualization for Global 1000 companies. As a pioneer in natural language processing and sentiment analysis, Attensity’s solutions identify relevant and accurate information from multi-channel data sources using highly sophisticated and patented semantic technologies, analytics and context based discovery. Using Attensity’s integrated solutions, enterprise companies can interpret and “understand” massive amounts of structured and unstructured data from many different sources, thereby helping to improve the customer experience, manage brand equity, enhance revenue, mitigate business risk, and help inform business strategies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.